Exploring transcription factors-microRNAs co-regulation networks in schizophrenia

Schizophrenia Bulletin

Volumn 42, Issue 4, 2016, Pages 1037-1045

  Xu, Yong ^a   Yue, Weihua ^b,c   Shugart, Yin Yao ^d   Li, Sheng ^e   Cai, Lei ^e   Li, Qiang ^f   Cheng, Zaohuo ^g   Wang, Guoqiang ^g   Zhou, Zhenhe ^g   Jin, Chunhui ^g   Yuan, Jianmin ^g   Tian, Lin ^g   Wang, Jun ^g   Zhang, Kai ^g   Zhang, Kerang ^a   Liu, Sha ^a   Song, Yuqing ^b   Zhang, Fuquan ^g  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^c BEIJING HOSPITAL   (China)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

^f CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^g NANJING MEDICAL UNIVERSITY   (China)

Author keywords

EGRl; MicroRNA; MiR 124 3p; Schizophrenia; Transcriptional factor

Indexed keywords

MICRORNA; MICRORNA 124 3P; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; MIRN124 MICRORNA, HUMAN; ONCOPROTEIN; SIGNAL PEPTIDE; SKIL PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; EGR1 GENE; FEMALE; GENE; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; HUMAN; MALE; MICROARRAY ANALYSIS; ONSET AGE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SKIL GENE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED;

ADULT; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRORNAS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; SCHIZOPHRENIA; TRANSCRIPTION FACTORS;

EID: 84979243323     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv170     Document Type: Article

References (58)

1. Clemmensen L, Vernal DL, Steinhausen HC. A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry. 2012;12:150.
2. Oldham MC, Horvath S, Geschwind DH. Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc Natl Acad Sci USA. 2006;103:17973-17978.
3. Okamura Y, Aoki Y, Obayashi T, et al. COXPRESdb in 2015: coexpression database for animal species by DNAmicroarray and RNAseq-based expression data with multiple quality assessment systems. Nucleic Acids Res. 2015;43:D82-86.
4. Gaiteri C, Ding Y, French B, Tseng GC, Sibille E. Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav. 2014;13:13-24.
5. de la Fuente A. From 'differential expression' to 'differential networking'-identification of dysfunctional regulatory networks in diseases. Trends Genet. 2010;26:326-333.
6. Yang J, Yu H, Liu BH, et al. DCGL v2.0: an R package for unveiling differential regulation from differential co-expression. PLoS One. 2013;8:e79729.
7. Torkamani A, Dean B, Schork NJ, Thomas EA. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res. 2010;20:403-412.
8. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474:380-384.
9. de Jong S, Boks MP, Fuller TF, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One. 2012;7:e39498.
10. Ponomarev I, Wang S, Zhang L, Harris RA, Mayfield RD. Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence. J Neurosci. 2012;32:1884-1897.
11. Chen C, Cheng L, Grennan K, et al. Two gene co-expression modules differentiate psychotics and controls. Mol Psychiatry. 2013;18:1308-1314.
12. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
13. Marco A, Konikoff C, Karr TL, Kumar S. Relationship between gene co-expression and sharing of transcription factor binding sites in Drosophila melanogaster. Bioinformatics. 2009;25:2473-2477.
14. Bandyopadhyay S, Bhattacharyya M. Analyzing miRNA coexpression networks to explore TF-miRNA regulation. BMC Bioinformatics. 2009;10:163.
15. Gennarino VA, D'Angelo G, Dharmalingam G, et al. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res. 2012;22:1163-1172.
16. Liu BH, Yu H, Tu K, Li C, Li YX, Li YY. DCGL: an R package for identifying differentially coexpressed genes and links from gene expression microarray data. Bioinformatics. 2010;26:2637-2638.
17. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744-747.
18. Steinberg S, de Jong S, Irish Schizophrenia Genomics Consortium, et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet. 2011;20:4076-4081.
19. Navarrete K, Pedroso I, De Jong S, et al. TCF4 (e2-2; ITF2): a schizophrenia-associated gene with pleiotropic effects on human disease. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:1-16.
20. Todorova VK, Elbein AD, Kyosseva SV. Increased expression of c-Jun transcription factor in cerebellar vermis of patients with schizophrenia. Neuropsychopharmacology. 2003;28:1506-1514.
21. Ahn YM, Seo MS, Kim SH, et al. Reduction in the protein level of c-Jun and phosphorylation of Ser73-c-Jun in rat frontal cortex after repeated MK-801 treatment. Psychiatry Res. 2009;167:80-87.
22. Cheng MC, Chuang YA, Lu CL, et al. Genetic and functional analyses of early growth response (EGR) family genes in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39:149-155.
23. Kyosseva SV. Differential expression of mitogen-activated protein kinases and immediate early genes fos and jun in thalamus in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:997-1006.
24. Suzuki G, Satow A, Ohta H. Effect of CFMTI, an allosteric metabotropic glutamate receptor 1 antagonist with antipsychotic activity, on Fos expression in regions of the brain related to schizophrenia. Neuroscience. 2010;168:787-796.
25. Yamada K, Gerber DJ, Iwayama Y, et al. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci USA. 2007;104:2815-2820.
26. Pérez-Santiago J, Diez-Alarcia R, Callado LF, et al. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. J Psychiatr Res. 2012;46:1464-1474.
27. O'Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40:1053-1055.
28. Mellios N, Sur M. The emerging role of microRNAs in schizophrenia and autism spectrum disorders. Front Psychiatry. 2012;3:39.
29. Zhang HM, Kuang S, Xiong X, Gao T, Liu C, Guo AY. Transcription factor and microRNA co-regulatory loops: important regulatory motifs in biological processes and diseases. Brief Bioinform. 2015;16:45-58.
30. Shalgi R, Lieber D, Oren M, Pilpel Y. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol. 2007;3:e131.
31. Tsang J, Zhu J, van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell. 2007;26:753-767.
32. RCoreTeam. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2014.
33. Franceschini A, Szklarczyk D, Frankild S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808-815.
34. Ru Y, Kechris KJ, Tabakoff B, et al. The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42:e133.
35. Wang J, Lu M, Qiu C, Cui Q. TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res. 2010;38:D119-122.
36. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-2504.
37. Wickham H. Ggplot2: Elegant Graphics for Data Analysis. New York: Springer; 2009.
38. Griffith M, Griffith OL, Coffman AC, et al. DGIdb: mining the druggable genome. Nat Methods. 2013;10:1209-1210.
39. Fang H, Gough J. The 'dnet' approach promotes emerging research on cancer patient survival. Genome Med. 2014;6:64.
40. Prieto C, Risueño A, Fontanillo C, De las Rivas J. Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles. PLoS One. 2008;3:e3911.
41. Simon R. BRB-Array Tools. Bethesda, MD: Biometric Research Branch, National Cancer Institute. 2015. http://linus. nci.nih.gov/BRB-ArrayTools.html. Accessed June 21, 2015.
42. Zhang F, Xu Y, Shugart YY, et al. Converging evidence implicates the abnormal microRNA system in schizophrenia. Schizophr Bull. 2015;41:728-735.
43. Wang W, Zhou D, Shi X, et al. Global Egr1-miRNAs binding analysis in PMA-induced K562 cells using ChIP-Seq. J Biomed Biotechnol. 2010;2010:1-11.
44. Cattane N, Minelli A, Milanesi E, et al. Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood. PLoS One. 2015;10:e0116686.
45. Veyrac A, Besnard A, Caboche J, Davis S, Laroche S. The transcription factor Zif268/Egr1, brain plasticity, and memory. Prog Mol Biol Transl Sci. 2014;122:89-129.
46. Koldamova R, Schug J, Lefterova M, et al. Genomewide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration. Neurobiol Dis. 2014;63:107-114.
47. Zhu Q, Luo K. SnoN in regulation of embryonic development and tissue morphogenesis. FEBS Lett. 2012;586:1971-1976.
48. Pan D, Zhu Q, Conboy MJ, Conboy IM, Luo K. SnoN activates p53 directly to regulate aging and tumorigenesis. Aging Cell. 2012;11:902-911.
49. Sonntag KC, Woo TU, Krichevsky AM. Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. Exp Neurol. 2012;235:427-435.
50. Tabarés-Seisdedos R, Rubenstein JL. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol Psychiatry. 2009;14:563-589.
51. Vaishnavi V, Manikandan M, Tiwary BK, Munirajan AK. Insights on the functional impact of microRNAs present in autism-associated copy number variants. PLoS One. 2013;8:e56781.
52. Fang M, Wang J, Zhang X, et al. The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimer's disease. Toxicol Lett. 2012;209:94-105.
53. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252-263.
54. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature. 2008;455:64-71.
55. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3:651-662.
56. Vogel TP, Milner JD, Cooper MA. The Ying and Yang of STAT3 in Human Disease. J Clin Immunol. 2015;35:615-623.
57. McGrath JJ, Féron FP, Burne TH, Mackay-Sim A, Eyles DW. Vitamin D3-implications for brain development. J Steroid Biochem Mol Biol. 2004;89-90:557-560.
58. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21-30.